Cargando…
Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center
BACKGROUND: The recent introduction of an entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. This is a single-center observational study of S-ICD implantations in Poland. METHODS: Th...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084361/ https://www.ncbi.nlm.nih.gov/pubmed/29611175 http://dx.doi.org/10.5603/CJ.a2018.0024 |
_version_ | 1783686140098772992 |
---|---|
author | Grabowski, Marcin Gawałko, Monika Michalak, Marcin Cacko, Andrzej Kowara, Michał Kołodzińska, Agnieszka Januszkiewicz, Łukasz Balsam, Paweł Serdoz, Laura Vitali Winter, Joachim Opolski, Grzegorz |
author_facet | Grabowski, Marcin Gawałko, Monika Michalak, Marcin Cacko, Andrzej Kowara, Michał Kołodzińska, Agnieszka Januszkiewicz, Łukasz Balsam, Paweł Serdoz, Laura Vitali Winter, Joachim Opolski, Grzegorz |
author_sort | Grabowski, Marcin |
collection | PubMed |
description | BACKGROUND: The recent introduction of an entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. This is a single-center observational study of S-ICD implantations in Poland. METHODS: The S-ICD was implanted in 11 patients with standard indications for an ICD. Patients in whom the device was implanted were evaluated for adverse events and device function at hospital discharge. All hospitalization costs were calculated and summed up for all patients. Costs were divided into following categories: medical materials, pharmaceuticals, operating theatre staff, cardiology department staff, laboratory tests, non-laboratory tests and additional non-medical costs. RESULTS: The mean age of patients was 51.6 ± 16.4 years, 9 were men and 2 were women. Four patients had atrial fibrillation as the basal rhythm, 1 patient had atrial flutter and 6 patients had sinus rhythm. All patients had at least one condition that precluded the use of a traditional ICD system or the S-ICD was preferred due to other conditions, i.e. a history complicated transvenous ICD therapy (18%), anticipated higher risk of infection (27%), lack or difficult vascular access (18%), young age and anticipated high cumulated risk of lifetime device therapy (36%). The mean duration of the implantation procedure was 2 h. One patient developed a postoperative pocket hematoma. Mean total time of hospitalization was 28 (6–92) days. Average cost of hospitalization per patient was 21,014.29 EUR (minimal = 19,332.71 EUR and maximal = 24,824.14 EUR). CONCLUSIONS: S-ICD implantation appears to provide a viable alternative to transvenous ICD, especially for patients without pacing requirements. |
format | Online Article Text |
id | pubmed-8084361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Via Medica |
record_format | MEDLINE/PubMed |
spelling | pubmed-80843612021-05-10 Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center Grabowski, Marcin Gawałko, Monika Michalak, Marcin Cacko, Andrzej Kowara, Michał Kołodzińska, Agnieszka Januszkiewicz, Łukasz Balsam, Paweł Serdoz, Laura Vitali Winter, Joachim Opolski, Grzegorz Cardiol J Clinical Cardiology BACKGROUND: The recent introduction of an entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. This is a single-center observational study of S-ICD implantations in Poland. METHODS: The S-ICD was implanted in 11 patients with standard indications for an ICD. Patients in whom the device was implanted were evaluated for adverse events and device function at hospital discharge. All hospitalization costs were calculated and summed up for all patients. Costs were divided into following categories: medical materials, pharmaceuticals, operating theatre staff, cardiology department staff, laboratory tests, non-laboratory tests and additional non-medical costs. RESULTS: The mean age of patients was 51.6 ± 16.4 years, 9 were men and 2 were women. Four patients had atrial fibrillation as the basal rhythm, 1 patient had atrial flutter and 6 patients had sinus rhythm. All patients had at least one condition that precluded the use of a traditional ICD system or the S-ICD was preferred due to other conditions, i.e. a history complicated transvenous ICD therapy (18%), anticipated higher risk of infection (27%), lack or difficult vascular access (18%), young age and anticipated high cumulated risk of lifetime device therapy (36%). The mean duration of the implantation procedure was 2 h. One patient developed a postoperative pocket hematoma. Mean total time of hospitalization was 28 (6–92) days. Average cost of hospitalization per patient was 21,014.29 EUR (minimal = 19,332.71 EUR and maximal = 24,824.14 EUR). CONCLUSIONS: S-ICD implantation appears to provide a viable alternative to transvenous ICD, especially for patients without pacing requirements. Via Medica 2019-08-22 /pmc/articles/PMC8084361/ /pubmed/29611175 http://dx.doi.org/10.5603/CJ.a2018.0024 Text en Copyright © 2019 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. |
spellingShingle | Clinical Cardiology Grabowski, Marcin Gawałko, Monika Michalak, Marcin Cacko, Andrzej Kowara, Michał Kołodzińska, Agnieszka Januszkiewicz, Łukasz Balsam, Paweł Serdoz, Laura Vitali Winter, Joachim Opolski, Grzegorz Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center |
title | Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center |
title_full | Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center |
title_fullStr | Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center |
title_full_unstemmed | Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center |
title_short | Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center |
title_sort | initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single polish center |
topic | Clinical Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084361/ https://www.ncbi.nlm.nih.gov/pubmed/29611175 http://dx.doi.org/10.5603/CJ.a2018.0024 |
work_keys_str_mv | AT grabowskimarcin initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT gawałkomonika initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT michalakmarcin initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT cackoandrzej initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT kowaramichał initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT kołodzinskaagnieszka initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT januszkiewiczłukasz initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT balsampaweł initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT serdozlauravitali initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT winterjoachim initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter AT opolskigrzegorz initialexperiencewiththesubcutaneousimplantablecardioverterdefibrillatorwiththerealcostsofhospitalizationanalysisinasinglepolishcenter |